293 related articles for article (PubMed ID: 14767026)
1. The incidence of treated end-stage renal disease in New Zealand Maori and Pacific Island people and in Indigenous Australians.
Stewart JH; McCredie MR; McDonald SP
Nephrol Dial Transplant; 2004 Mar; 19(3):678-85. PubMed ID: 14767026
[TBL] [Abstract][Full Text] [Related]
2. Incidence of end-stage renal disease in overseas-born, compared with Australian-born, non-indigenous Australians.
Stewart JH; McCredie MR; McDonald SP
Nephrology (Carlton); 2004 Aug; 9(4):247-52. PubMed ID: 15363057
[TBL] [Abstract][Full Text] [Related]
3. Increases in renal replacement therapy in Australia and New Zealand: understanding trends in diabetic nephropathy.
Grace BS; Clayton P; McDonald SP
Nephrology (Carlton); 2012 Jan; 17(1):76-84. PubMed ID: 21854505
[TBL] [Abstract][Full Text] [Related]
4. Interpreting incidence trends for treated end-stage renal disease: implications for evaluating disease control in Australia.
Stewart JH; McCredie MR; Williams SM; McDonald SP
Nephrology (Carlton); 2004 Aug; 9(4):238-46. PubMed ID: 15363056
[TBL] [Abstract][Full Text] [Related]
5. Inequity in dialysis related practices and outcomes in Aotearoa/New Zealand: a Kaupapa Māori analysis.
Huria T; Palmer S; Beckert L; Williman J; Pitama S
Int J Equity Health; 2018 Feb; 17(1):27. PubMed ID: 29458366
[TBL] [Abstract][Full Text] [Related]
6. Geographic, ethnic, age-related and temporal variation in the incidence of end-stage renal disease in Europe, Canada and the Asia-Pacific region, 1998-2002.
; Stewart JH; McCredie MR; Williams SM
Nephrol Dial Transplant; 2006 Aug; 21(8):2178-83. PubMed ID: 16595584
[TBL] [Abstract][Full Text] [Related]
7. The enigma of hypertensive ESRD: observations on incidence and trends in 18 European, Canadian, and Asian-Pacific populations, 1998 to 2002.
Stewart JH; McCredie MR; Williams SM; ; Fenton SS; Trpeski L; ; McDonald SP; ; Jager KJ; van Dijk PC; ; Finne P; ; Schon S; ; Leivestad T; ; Løkkegaard H; ; Billiouw JM; ; Kramar R; ; Magaz A; ; Vela E; ; Garcia-Blasco MJ; ; Ioannidis GA; ; Lim YN
Am J Kidney Dis; 2006 Aug; 48(2):183-91. PubMed ID: 16860183
[TBL] [Abstract][Full Text] [Related]
8. Social disparities in the prevalence of diabetes in Australia and in the development of end stage renal disease due to diabetes for Aboriginal and Torres Strait Islanders in Australia and Maori and Pacific Islanders in New Zealand.
Hill K; Ward P; Grace BS; Gleadle J
BMC Public Health; 2017 Oct; 17(1):802. PubMed ID: 29020957
[TBL] [Abstract][Full Text] [Related]
9. Current incidence, treatment patterns and outcome of end-stage renal disease among indigenous groups in Australia and New Zealand.
McDonald SP; Russ GR
Nephrology (Carlton); 2003 Feb; 8(1):42-8. PubMed ID: 15012749
[TBL] [Abstract][Full Text] [Related]
10. Gender differences in the dialysis treatment of Indigenous and non-Indigenous Australians.
McKercher C; Jose MD; Grace B; Clayton PA; Walter M
Aust N Z J Public Health; 2017 Feb; 41(1):15-20. PubMed ID: 27960225
[TBL] [Abstract][Full Text] [Related]
11. ESRD in Australia and New Zealand at the end of the millennium: a report from the ANZDATA registry.
McDonald SP; Russ GR; Kerr PG; Collins JF;
Am J Kidney Dis; 2002 Dec; 40(6):1122-31. PubMed ID: 12460029
[TBL] [Abstract][Full Text] [Related]
12. Burden of end-stage renal disease among indigenous peoples in Australia and New Zealand.
McDonald SP; Russ GR
Kidney Int Suppl; 2003 Feb; (83):S123-7. PubMed ID: 12864890
[TBL] [Abstract][Full Text] [Related]
13. Demography and survival of patients receiving treatment for chronic renal failure in Australia and New Zealand: report on dialysis and renal transplantation treatment from the Australia and New Zealand Dialysis and Transplant Registry.
Disney AP
Am J Kidney Dis; 1995 Jan; 25(1):165-75. PubMed ID: 7810521
[TBL] [Abstract][Full Text] [Related]
14. Regional variation in the incidence of end-stage renal disease in Indigenous Australians.
Cass A; Cunningham J; Wang Z; Hoy W
Med J Aust; 2001 Jul; 175(1):24-7. PubMed ID: 11476198
[TBL] [Abstract][Full Text] [Related]
15. Bronchiectasis in indigenous and non-indigenous residents of Australia and New Zealand.
Blackall SR; Hong JB; King P; Wong C; Einsiedel L; Rémond MGW; Woods C; Maguire GP
Respirology; 2018 Aug; 23(8):743-749. PubMed ID: 29502335
[TBL] [Abstract][Full Text] [Related]
16. Incidence and treatment of ESRD among indigenous peoples of Australasia.
McDonald S
Clin Nephrol; 2010 Nov; 74 Suppl 1():S28-31. PubMed ID: 20979960
[TBL] [Abstract][Full Text] [Related]
17. Incidence of cancer among Pacific Island people in New Zealand.
Tukuitonga CF; Solomon N; Stewart A
N Z Med J; 1992 Nov; 105(946):463-6. PubMed ID: 1436871
[TBL] [Abstract][Full Text] [Related]
18. Exploring the pathways leading from disadvantage to end-stage renal disease for indigenous Australians.
Cass A; Cunningham J; Snelling P; Wang Z; Hoy W
Soc Sci Med; 2004 Feb; 58(4):767-85. PubMed ID: 14672592
[TBL] [Abstract][Full Text] [Related]
19. The long-term outcome of New Zealand Maori and Pacific Island children diagnosed with childhood onset lupus nephritis.
Concannon A; Wong W; Han DY
Lupus; 2022 Nov; 31(13):1671-1678. PubMed ID: 36168149
[TBL] [Abstract][Full Text] [Related]
20. Trends in incidence of treated end-stage renal disease, overall and by primary renal disease, in persons aged 20-64 years in Europe, Canada and the Asia-Pacific region, 1998-2002.
Stewart JH; McCredie MR; Williams SM; Jager KJ; Trpeski L; McDonald SP;
Nephrology (Carlton); 2007 Oct; 12(5):520-7. PubMed ID: 17803478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
